When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers. “A lot of people didn’t think it would work ...
Who would not be a good candidate for TMS? Patients with anxiety but without depression may not respond to TMS. People who are pregnant, are at high risk of seizure, or who have epilepsy or ...
During the first 9 months of the pandemic, Americans reported rates of depression and anxiety six times higher than in 2019, Boston College researchers find Confirming anecdotal evidence that the ...